Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Erickson

Showing results (371-380 of 383) with videos related to

Pageof 39
Sort By:
The American Journal of Pathology|October 24, 2009
Identification of EpCAM as a molecular target of prostate cancer stromaSumana Mukherjee, Annely M Richardson, Jaime Rodriguez-Canales, et al.
Journal of Translational Medicine|October 6, 2010
Increased matrix metalloproteinase activation in esophageal squamous cell carcinomaSumana Mukherjee, Mark J Roth, Sanford M Dawsey, et al.
The American Journal of Pathology|December 11, 2012
Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinomaWusheng Yan, Joanna Shih, Jaime Rodriguez-Canales, et al.
JAMA Surgery|August 4, 2016
Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical TrialChristopher R Connelly, Philbert Y Van, Kyle D Hart, et al.
Obesity (Silver Spring, Md.)|June 19, 2010
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trialThomas A Wadden, John P Foreyt, Gary D Foster, et al.
Anaesthesia and Intensive Care|October 6, 2011
Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New ZealandR J Boots, J Lipman, M Lassig-Smith, et al.
Journal of Medicinal Chemistry|May 9, 1997
Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: synthesis, structure-activity relationship, and X-ray crystal structure analysisD A Nugiel, K Jacobs, L Cornelius, et al.
Journal of Medicinal Chemistry|May 23, 1998
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studiesP K Jadhav, F J Woerner, P Y Lam, et al.
The Journal of Pathology|February 6, 2007
Identification of a unique epigenetic sub-microenvironment in prostate cancerJ Rodriguez-Canales, J C Hanson, M A Tangrea, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Pageof 39

Showing results (371-380 of 383) with videos related to

Sort By:
Pageof 39
The American Journal of Pathology|October 24, 2009
Identification of EpCAM as a molecular target of prostate cancer stromaSumana Mukherjee, Annely M Richardson, Jaime Rodriguez-Canales, et al.
Journal of Translational Medicine|October 6, 2010
Increased matrix metalloproteinase activation in esophageal squamous cell carcinomaSumana Mukherjee, Mark J Roth, Sanford M Dawsey, et al.
The American Journal of Pathology|December 11, 2012
Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinomaWusheng Yan, Joanna Shih, Jaime Rodriguez-Canales, et al.
JAMA Surgery|August 4, 2016
Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical TrialChristopher R Connelly, Philbert Y Van, Kyle D Hart, et al.
Obesity (Silver Spring, Md.)|June 19, 2010
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trialThomas A Wadden, John P Foreyt, Gary D Foster, et al.
Anaesthesia and Intensive Care|October 6, 2011
Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New ZealandR J Boots, J Lipman, M Lassig-Smith, et al.
Journal of Medicinal Chemistry|May 9, 1997
Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: synthesis, structure-activity relationship, and X-ray crystal structure analysisD A Nugiel, K Jacobs, L Cornelius, et al.
Journal of Medicinal Chemistry|May 23, 1998
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studiesP K Jadhav, F J Woerner, P Y Lam, et al.
The Journal of Pathology|February 6, 2007
Identification of a unique epigenetic sub-microenvironment in prostate cancerJ Rodriguez-Canales, J C Hanson, M A Tangrea, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Pageof 39